Op-Eds Trump FDA’s chance to crack down on Chinese black market harming our children Richard Burr · June 8, 2026 8:00 am
Healthcare FDA launches mifepristone study after pressure from Trump’s right flank Rena Rowe · June 5, 2026 11:55 am
Op-Eds Michael Bloomberg’s war on vaping puts criminals over consumers Martin Cullip · June 4, 2026 10:00 am
Op-Eds The FDA is moving faster on psychedelics — now Washington must do more Peter Pitts · June 3, 2026 9:00 am
Healthcare Name tweak could boost GLP-1 access for one in eight women suffering PMOS Gabrielle M. Etzel · May 31, 2026 7:00 am
Healthcare Tom Cotton warns FDA about cybersecurity threat from Chinese-made medical devices Gabrielle M. Etzel · May 26, 2026 4:15 pm
Community and Family Dobbs gave states power. Mifepristone took it back Gabriella McIntyre · May 24, 2026 6:00 am
Healthcare New Eli Lilly weight loss drug has dramatic effects in clinical trial Gabrielle M. Etzel · May 21, 2026 12:32 pm
Op-Eds Illicit vapes flooded our borders. The Trump administration is fighting back Tricia McLaughlin · May 21, 2026 9:20 am
Op-Eds American mothers are done being China’s vape dumping ground Emily Stack · May 20, 2026 7:00 am